4//SEC Filing
Morag Eyal 4
Accession 0001493152-22-002553
CIK 0000883975other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:30 PM ET
Size
5.8 KB
Accession
0001493152-22-002553
Insider Transaction Report
Form 4
Morag Eyal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-26+25,000→ 25,000 totalExercise: $6.48Exp: 2032-01-26→ Common Stock, par value $0.01 per share (25,000 underlying)
Footnotes (1)
- [F1]The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on July 26, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.
Documents
Issuer
Microbot Medical Inc.
CIK 0000883975
Entity typeother
Related Parties
1- filerCIK 0001805787
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:30 PM ET
- Size
- 5.8 KB